Volume: September 2022, Double Issue

Sep 1, 2022 | Hot Topics

AARS News

  • AARS BoD Member Emmy Graber invites you to earn free CME!

New Medical Research

  • Adverse-event reports in over-the-counter topical acne drug products containing benzoyl peroxide from a specific pharmaceutical company in the USA.
  • Antibacterial and anti-inflammatory activities of thymus vulgaris essential oil nanoemulsion on acne vulgaris.
  • Influence of selected food product groups consumption frequency on acne-related quality of life in a national sample of polish female adolescents.
  • Novel technique for rosacea treatment using optimal pulse technology: In vivo and clinical studies.
  • Quantitative evaluation of the effectiveness of chemical peelings in reducing acne lesions based on Gray-Level Co-Occurrence Matrix (GLCM).
  • High-frequency devices effect in vitro: promising approach in the treatment of acne vulgaris?
  • Evaluating the effectiveness of stromal-vascular fraction (SVF) cells along with subcision method in the treatment of acne scars: A double-blind randomized controlled clinical trial study.
  • Evaluation of serum TWEAK, TRAIL, and oxidative stress markers in rosacea patients.
  • Acne and its post-inflammatory hyperpigmentation treatment by anti-acne dissolving microneedle patches.
  • Meta-analysis of fractional radiofrequency treatment for acne and/or acne scars.
  • Skin barrier deficiency in rosacea: an algorithm integrating otc skincare products into treatment regimens.
  • The role of epidermal barrier dysfunction and cutaneous microbiome dysbiosis in the pathogenesis and management of acne vulgaris and rosacea.
  • Reasons why adults do not seek treatment for acne: A survey of university students and staff.
  • Clinical efficacy and safety of pulsed dye laser combined with pingyangmycin on hyperplastic scar after acne.
  • Hidradenitis suppurativa: A perspective on genetic factors involved in the disease.
  • Association between frontal fibrosing alopecia and rosacea: Results from clinical observational studies and gene expression profiles.
  • A novel multi-layer perceptron model for assessing the diagnostic value of non-invasive imaging instruments for rosacea.
  • Montelukast as an effective adjuvant in the treatment of moderate acne vulgaris.
  • A comparative study of dermatoscopic features of acne-related postinflammatory hyperpigmentation in facial and nonfacial areas in Asian patients.
  • Genomic and phenotypic characterization of cutibacterium acnes bacteriophages isolated from acne patients.
  • The use of isotretinoin in acne therapy in early childhood and its effect on the occurrence of acne symptoms later in life. Eight-year follow-up.
  • Antibiotic resistance risk with oral tetracycline treatment of acne vulgaris.
  • Myths, misconceptions, and attitudinal trends among patients with acne.

Clinical Reviews

  • Demographic gaps and requirements for participation: A systematic review of clinical trial designs in hidradenitis suppurativa.
  • Trifarotene 0.005% cream in the treatment of facial and truncal acne vulgaris in patients with skin of color: A case series.
  • Racial and ethnic diversity of US participants in clinical trials for acne, atopic dermatitis, and psoriasis: A comprehensive review.
  • Management of acne in transgender and gender diverse youth. Part 1: Gender affirming care and risk factors for the development of acne.
  • Immunomodulatory drugs in the treatment of hidradenitis suppurativa-possibilities and limitations.
  • Management of acne in transgender and gender diverse youth. Part 2: Unique considerations and strategies in medical treatment.
  • Phytotherapeuthics affecting the IL-1/IL-17/G-CSF Axis: A complementary treatment option for hidradenitis suppurativa?
  • The synergy between pharmacological regimens and dermocosmetics and its impact on adherence in acne treatment.
  • Lasers for the treatment of erythema, dyspigmentation, and decreased elasticity in macular acne scars: A systematic review.
  • Innate immunity and microbial dysbiosis in hidradenitis suppurativa – vicious cycle of chronic inflammation.
  • Combination radiofrequency microneedling and carbon dioxide laser for acne scarring: A systematic review and retrospective case series across two centers.

Related Posts

Volume: July 2024, Issue 1

Volume: July 2024, Issue 1

AARS News AARS July Membership Discount Available to HCPs Amid Paucity of Innovation, New Acne Treatment Guidelines Overlook Critical Issues: Editorial AARS Spotlights #AcneFacts During National Acne Awareness Month AARS Goes One-on-One with Dermatologist Sandra Lee,...

Volume: June 2024, Issue 1

Volume: June 2024, Issue 1

AARS News   Highlights from the 11th Annual AARS Annual Scientific Symposium New Medical Research Isotretinoin for acne in transgender and gender-diverse individuals receiving masculinizing hormone therapy. Efficacy and safety of bimekizumab in patients with...

Volume: May 2024, Issue 1

Volume: May 2024, Issue 1

AARS News   AARS Call for Grant Applications New Medical Research Triple combination clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% for acne: Efficacy and safety from a pooled phase 3 analysis. The role of vitamins and nutrients in rosacea....

Volume: July 2024, Issue 1

Volume: April 2024, Issue 1

AARS News   Register now for the 11th Annual AARS Scientific Symposium AARS Call for Grant Applications Response Statement from the American Acne & Rosacea Society to the Valisure Citizen Petition on Benzene in Benzoyl Peroxide Drug Products New Medical...